Literature DB >> 2875660

Pressor resistance to vasopressin in sodium depletion, potassium depletion, and cirrhosis.

B M Murray, M S Paller.   

Abstract

Resistance to the pressor effects of angiotensin II, but not norepinephrine, has been observed in sodium depletion, potassium depletion, and cirrhosis. We tested the response to arginine vasopressin (AVP) in each of these conditions. Male Sprague-Dawley rats were made sodium depleted with furosemide and a low-sodium diet for 3 days, potassium depleted by feeding a low-potassium diet for 14-21 days, or cirrhotic by inhalation of carbon tetrachloride for 8 wk. In conscious rats, the pressor response to graded doses of AVP was reduced in sodium depletion by 27-43% compared with control rats. Sodium-depleted rats were also found to have enhanced baroreceptor reflexes, since the decrease in heart rate for a given increase in mean arterial pressure was greater than in control rats. When the ganglionic blocker pentolinium tartrate was given to sodium-depleted rats the pressor response to AVP was restored to control levels. In potassium-depleted rats the pressor response to AVP was 21-52% lower than that in controls, whereas cirrhotic rats also had a blunted response to AVP (14-41% lower than control). However, there was no evidence in either of these two states of enhanced baroreceptor activity, and pretreatment with pentolinium tartrate did not restore the pressor response to normal. Therefore, although resistance to the pressor effect of AVP was found in all three conditions, the mechanism of this effect was different in sodium depletion compared with potassium depletion and cirrhosis. We conclude that resistance to the pressor action of AVP in sodium depletion was secondary to resetting of the baroreceptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875660     DOI: 10.1152/ajpregu.1986.251.3.R525

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  Portal hypertension--25 years of progress.

Authors:  B R MacDougall; D Westaby; L A Blendis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Vascular contractile response and signal transduction in endothelium-denuded aorta from cirrhotic rats.

Authors:  Han-Chieh Lin; Ying-Ying Yang; Yi-Tsau Huang; Tzung-Yan Lee; Ming-Chih Hou; Fa-Yauh Lee; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

3.  Murine study of portal hypertension associated endothelin-1 hypo-response.

Authors:  Nicholas Theodorakis; Mary Maluccio; Nicholas Skill
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

4.  Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.

Authors:  P Y Martin; M Ohara; P Gines; D L Xu; J St John; M Niederberger; R W Schrier
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

5.  H,K-ATPase type 2 contributes to salt-sensitive hypertension induced by K(+) restriction.

Authors:  Christine Walter; Mariem Ben Tanfous; Katia Igoudjil; Amel Salhi; Geneviève Escher; Gilles Crambert
Journal:  Pflugers Arch       Date:  2016-08-25       Impact factor: 3.657

6.  Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension.

Authors:  S H Thomas; T Joh; J N Benoit
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

7.  Study on the vascular reactivity and alpha 1-adrenoceptors of portal hypertensive rats.

Authors:  J F Liao; P C Yu; H C Lin; F Y Lee; J S Kuo; M C Yang
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

8.  Role of protein kinase C in mesenteric pressor responses of rats with portal hypertension.

Authors:  N M Atucha; M C Ortíz; C Martínez; T Quesada; J García-Estañ
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.